Back to Journals » OncoTargets and Therapy » Volume 16

Case report

Sustained Clinical Response to 4th-Line Therapy with Selpercatinib in RET Fusion-Positive Combined Small Cell Lung Cancer

       
Total article views   HTML views PDF downloads Totals
2,209 Dovepress* 2,100+ 59 2,159
PubMed Central* 109 34 143
Totals 2,209 93 2,302
*Since 29 November 2023

View citations on PubMed Central and Google Scholar